Overview

Insulin Sensitizers Role in Control of PCOS Vicious Cycle.

Status:
Completed
Trial end date:
2023-04-15
Target enrollment:
Participant gender:
Summary
PCOS is a common and complex disease affecting women of reproductive age. It is characterized by its complex pathological symptoms and mechanisms resulting in endocrine and metabolic dysfunction. PCOS is highly associated with various metabolic and endocrinal disorders. Metformin is mainly used for its glucose-lowering effects for treatment and prevention of type-2 diabetes mellitus (DM), gestational DM, and PCOS. Myo-inositol (MI) protects against MAFLD through reduction of hepatic accumulation of triglycerides.
Phase:
Phase 1
Details
Lead Sponsor:
Zagazig University
Treatments:
Metformin